The role of pharmacotherapy and managed care pharmacy interventions in the treatment of ADHD.

The American journal of managed care

Volumn 15, Issue 5 Suppl, 2009, Pages

  Dopheide, Julie A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR AFFECTING AGENT; ATOMOXETINE; CENTRAL STIMULANT AGENT; DEXAMPHETAMINE; METHYLPHENIDATE; PROPYLAMINE;

ATTENTION DEFICIT DISORDER; HEALTH INSURANCE; HUMAN; PATIENT COMPLIANCE; REVIEW;

ADRENERGIC UPTAKE INHIBITORS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; DEXTROAMPHETAMINE; HUMANS; MANAGED CARE PROGRAMS; MEDICATION ADHERENCE; METHYLPHENIDATE; PROPYLAMINES;

EID: 70349778267     PISSN: None     EISSN: 19362692     Source Type: Journal    
DOI: None     Document Type: Review

References (38)